Table 4.

Sensitivity analysis: adjusted associations of FPG, 2-hr PPPG, GDM status (according to WHO 1999 definition) at 26 weeks’ gestation with cIMT, cfPWV, AIx, AIx@75 SBP and DBP at age 6 years excluding preterm children or mothers with GDM or children with negative AIx^a

	SBP, mmHg n = 452		DBP, mmHg n = 452
	β [CI 95%]		β [CI 95%]
	Unadjusted	Adjusteda	Unadjusted	Adjusteda
FPG, mmol/L	1.75 [0.13; 3.37]b	1.52 [-0.23; 3.26]	0.09 [-1.12; 1.30]	0.17 [-1.16; 1.50]
2-hr PPPG, mmol/L	-0.15 [-0.66; 0.37]	-0.02 [-0.58; 0.54]	-0.41[-0.79; -0.03]b	-0.36 [-0.78; 0.07]
GDMc	0.48 [0.04 ; 0.92]b	0.66 [-1.36; 2.69]	-0.10 [-0.42 ; 0.23]	0.20 [-1.33; 1.73]

^aMultiple linear and logistic regressions on multiple imputed datasets (n=20) also adjusted for study center, child’s sex, paternal height, maternal characteristics (ethnicity, age at delivery, height, pre-pregnancy BMI, educational attainment, BP category before 20 weeks of gestation, active smoking status at 26 weeks of gestation, exposure to tobacco at home and/or work in early pregnancy and at 26 weeks).

^bP-value<0.05.

^cGDM defined using WHO 1999 criteria.

Abbreviations: cIMT: carotid intima media thickness, cfPWV: carotid femoral pulse wave velocity, AIx: augmentation index, AIx@75: augmentation index normalized to a heart rate of 75 beats/min, SBP: systolic blood pressure, DBP: diastolic blood pressure, FPG: fasting plasma glucose, PPPG: postprandial plasma glucose, GDM: gestational diabetes mellitus.